Samrat Pharmachem Ltd. - Research Center
530125 SAMRATPH Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 281.58 | 310.65 | 221.81 | 179.02 | 137.45 |
| Expenses | |||||
| Material consumed | 270.32 | 277.87 | 189.90 | 164.25 | 125.62 |
| Manufacturing expenses | 3.58 | 4.01 | 3.77 | 2.86 | 2.24 |
| Personnel expenses | 2.22 | 1.88 | 1.77 | 1.50 | 1.44 |
| Selling expenses | 0.02 | 0.01 | 0.02 | 0.04 | 0.02 |
| Adminstrative expenses | 2.98 | 2.96 | 2.00 | 1.70 | 1.51 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 279.11 | 286.72 | 197.47 | 170.35 | 130.82 |
| Operating profit | 2.47 | 23.93 | 24.34 | 8.67 | 6.63 |
| Other recurring income | 1.38 | 0.48 | 0.55 | 0.46 | 0.57 |
| Adjusted PBDIT | 3.85 | 24.41 | 24.89 | 9.13 | 7.20 |
| Financial expenses | 0.69 | 1.23 | 0.67 | 1.28 | 0.98 |
| Depreciation | 0.65 | 0.64 | 0.59 | 0.49 | 0.43 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 2.52 | 22.53 | 23.62 | 7.36 | 5.80 |
| Tax charges | 0.36 | 5.90 | 6.42 | 2.01 | 1.55 |
| Adjusted PAT | 2.16 | 16.63 | 17.21 | 5.35 | 4.25 |
| Non recurring items | - | - | -0.02 | -0.02 | -0.01 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 2.16 | 16.63 | 17.18 | 5.33 | 4.24 |
| Earnigs before appropriation | 62.22 | 60.36 | 43.73 | 26.55 | 21.21 |
| Equity dividend | 0.31 | 0.31 | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 61.91 | 60.05 | 43.73 | 26.55 | 21.21 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis